National Egyptian Network Pediatric Stroke and Hemiplegia Registry
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02129491|
Recruitment Status : Recruiting
First Posted : May 2, 2014
Last Update Posted : May 2, 2014
|Condition or disease|
|Stroke With Hemiparesis Perinatal Stroke Focal Neurologic Deficits|
Aims: An open-ended multi-center, national Egyptian study to collect and analyze data for children with cerebrovascular stroke and hemiplegia .
Participants: Eligible infants and children with stroke and hemiplegia.
DESIGN: This study is a prospective cohort study.
Primary outcome measure: Initial acute stroke clinical and radiological presentation, recurrent stroke, mortality, and neurologic deficits in the acute stage, participants will be followed for the duration of hospital stay, an expected average of 6 weeks
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||1000 participants|
|Target Follow-Up Duration:||10 Years|
|Official Title:||National Egyptian Network Pediatric Stroke and Hemiplegia Registry|
|Study Start Date :||January 2014|
|Estimated Primary Completion Date :||January 2020|
|Estimated Study Completion Date :||December 2021|
Pediatric Stroke and Hemiplegia
Any infant or child with acute stroke or hemiplegia
- Survival or neurologic deficit after acute cerebrovascular stroke. [ Time Frame: participants will be followed for the duration of hospital stay, an expected average of 6 weeks ]Children with acute stroke will be followed till either death or discharge from hospital, all clinical, radiological and therapeutic data will be collected.
- Long term neurological deficit [ Time Frame: 12 months ]Post-stroke pediatric gross and fine motor function will be assessed.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02129491
|Contact: Sahar MA Hassanein, MD, PhDfirstname.lastname@example.org|
|Pediatric Department, Children's Hospital, Faculty of Medicine, Ain Shams University||Recruiting|
|Cairo, Abassia, Egypt, 11381|
|Contact: Mohsen S Elalfy, MD, PhD email@example.com|
|Principal Investigator: Sahar MA Hassanein, MD, PhD|
|Study Chair:||Sahar MA Hassanein, MD, PhD||Pediatric Department, Children's Hospital, Faculty of Medicine, Ain Shams University|